Laddar...
Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events
BACKGROUND: An increase in serious adverse events with the use of both regular formoterol and regular salmeterol (long-acting beta(2)-agonists) in chronic asthma has been demonstrated in comparison with placebo in previous Cochrane reviews. This increase was significant in trials that did not random...
Sparad:
| Huvudupphovsmän: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2010
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4015852/ https://ncbi.nlm.nih.gov/pubmed/20091646 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007694.pub2 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|